(HealthDay)—Many children who are initially successfully treated for allergy to cow's milk by oral immunotherapy lose tolerance several years later, according to a letter to the editor published online June 27 in the Journal ...
Jul 8, 2013
0
0
(HealthDay)—A substantially high number of patients undergoing spinal fusion have a vitamin D deficiency or inadequacy, according to a study published in the March 15 issue of Spine.
Mar 28, 2013
0
0
Drugmaker Bristol-Myers Squibb Co. is expanding its collaboration with Five Prime Therapeutics Inc., which could receive more than $1.75 billion if they succeed in turning Five Prime's antibody-based drug candidates into ...
Oct 15, 2015
0
11
The Cystic Fibrosis Foundation says it has sold royalty rights worth $3.3 billion for innovative drugs it helped develop with Vertex Pharmaceuticals Incorporated.
Nov 19, 2014
0
0
Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends contributed to ...
Oct 22, 2013
0
0
Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.
Jun 18, 2013
0
0
Shareholders of Irish drugmaker Elan Corp. PLC have potentially ended a takeover bid from Royalty Pharma by voting in favor of an Elan share buyback plan.
Jun 17, 2013
0
0
Shares of Elan Corp PLC jumped Friday after the Irish drugmaker said it will explore a possible sale of the company while its board continues to fend off a hostile takeover bid from Royalty Pharma.
Jun 14, 2013
0
0
Irish biotechnology company Elan rejected on Monday the latest takeover bid from US group Royalty Pharma worth about $7.9 billion (6.0 billion euros).
Jun 10, 2013
0
0
Shares of Elan Corp. PLC jumped Friday after Royalty Pharma once again raised its offer to buy the Irish drugmaker in an increasingly bitter takeover fight.
Jun 7, 2013
0
0
